The results of the survival analysis showed that RAB32 expression in HGG was negatively correlated with glioma survival, the overall survival (OS) time of HGG patients with RAB32 overexpression was shorter, and the results from the two databases were consistent (Figure 3A, D). This evidence concerns the gene RAB32 and central nervous system cancer.